Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease
Open Access
- 29 January 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 93 (6), 837-845
- https://doi.org/10.1189/jlb.0112023
Abstract
Indoxyl sulfate induced Mac-1 expression and ROS production via p38 MAPK- and NAD(P)H oxidase-dependent pathways. Accelerated cardiovascular disease is a frequent complication of CKD. Monocyte-mediated inflammation and adhesion of monocytes to vascular endothelium are key events in atherogenesis. An oral adsorbent, AST-120, retards renal function deterioration by lowering IS, which is known to accumulate in CKD patients. However, the effect of AST-120 on CKD-related monocyte activation is unknown. We aimed to determine whether AST-120 improves monocyte-mediated inflammation through IS reduction. Flow cytometric analysis showed that Mac-1 expression and ROS production were significantly higher in peripheral blood monocytes of subtotal Nx CKD mice than in sham-operated mice. AST-120 treatment significantly decreased Mac-1 expression and ROS production in CKD model mice. Furthermore, administration of IS induced monocyte-mediated inflammation and ROS generation. In vitro studies indicated that IS dose-dependently increased THP-1 monocytic cell adhesion to IL-1β-activated HUVECs under physiological flow conditions. IS also induced monocyte-mediated inflammation and ROS production in THP-1 cells. Phosphorylation of p38 MAPK and membrane translocation of NAD(P)H oxidase subunit p47phox in THP-1 cells were induced by IS. Both SB203580 (p38 MAPK inhibitor) and apocynin [NAD(P)H oxidase inhibitor] reduced THP-1 cell adhesion to HUVECs. Apocynin also inhibited IS-induced ROS production in THP-1 cells. IS induced monocyte-driven inflammation through NAD(P)H oxidase- and p38 MAPK-dependent pathways in monocytes. The main finding of this study was that AST-120 inhibited monocyte activation by reducing IS in vivo. This provides new insights on how AST-120 attenuates the progression of atherosclerosis in CKD.Keywords
This publication has 42 references indexed in Scilit:
- Cardiorenal SyndromeJournal of the American College of Cardiology, 2008
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationThe New England Journal of Medicine, 2004
- Pathophysiology Underlying Accelerated Atherogenesis in Renal DiseaseJournal of the American Society of Nephrology, 2004
- Atherosclerosis — An Inflammatory DiseaseThe New England Journal of Medicine, 1999
- A mAb to the β2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbitsProceedings of the National Academy of Sciences of the United States of America, 1998
- Deficiency of Inflammatory Cell Adhesion Molecules Protects Against Atherosclerosis in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Cardiovascular disease in patients with chronic renal failureThe Lancet, 1996
- Late Lumen Loss After Coronary Angioplasty Is Associated With the Activation Status of Circulating Phagocytes Before TreatmentCirculation, 1995
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Integrins: A family of cell surface receptorsCell, 1987